BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia [ChIP-Seq]
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Hijacking of primitive hematopoietic enhancers, or generation of a neo-enhancer by genomic amplification, results in deregulation of BCL11B as the defining feature of a subset of T/myeloid leukemia. We report H3K27ac and BCL11B binding in these Leukemias. H3K27ac and BCL11B binding in leukemia cells
创建时间：
2021-08-22
